Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Journal of the American Society of Nephrology : JASN
|
April 1, 2022
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Sushma Shankar, Joseph Beckett, Tom Tipton, et al.
Mbio
|
September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
British Journal of Haematology
|
November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients
Hayley Colton, Natalie Barratt, Nigel Temperton, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 26, 2021
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations
Anetta Ptasinska, Celina Whalley, Andrew Bosworth, et al.
Nature Communications
|
August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Nature Medicine
|
July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The European Respiratory Journal
|
June 5, 2025
Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19
Éanna Fennell, Graham S Taylor, Ciara I Leahy, et al.
The Lancet. Rheumatology
|
May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
Carl S Goodyear, Amit Patel, Eleanor Barnes, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 5, 2023
A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom
Patrick F K Yong, Tanya Coulter, Tariq El-Shanawany, et al.
The New England Journal of Medicine
|
June 10, 2026
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease
Nima Gharahdaghi, Pai-Jui Yeh, Lourdes Ceron-Gutierrez, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Journal of the American Society of Nephrology : JASN
|
April 1, 2022
SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients
Sushma Shankar, Joseph Beckett, Tom Tipton, et al.
Mbio
|
September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
British Journal of Haematology
|
November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients
Hayley Colton, Natalie Barratt, Nigel Temperton, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 26, 2021
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations
Anetta Ptasinska, Celina Whalley, Andrew Bosworth, et al.
Nature Communications
|
August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Nature Medicine
|
July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Eleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The European Respiratory Journal
|
June 5, 2025
Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19
Éanna Fennell, Graham S Taylor, Ciara I Leahy, et al.
The Lancet. Rheumatology
|
May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
Carl S Goodyear, Amit Patel, Eleanor Barnes, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 5, 2023
A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom
Patrick F K Yong, Tanya Coulter, Tariq El-Shanawany, et al.
The New England Journal of Medicine
|
June 10, 2026
Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease
Nima Gharahdaghi, Pai-Jui Yeh, Lourdes Ceron-Gutierrez, et al.
Page
of 11